SIM
MNTA

Sonora Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Sonora Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-260
Closed -$5K – 1220
2015
Q3 		$5K Buy
+260
New +$5.32K ﹤0.01% 763

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Sonora Investment Management's MNTA Position: Q4 2015 in Review

Sonora Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 260 shares — an estimated $5K sold.

Sonora Investment Management first reported a position in MNTA in Q3 2015 and held it in 1 quarter. The position peaked at $5K in Q3 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

  • Sonora Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Sonora Investment Management sold 260 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $5K.
  • Sonora Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Sonora Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $5K in Q3 2015.
  • 164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on Sonora Investment Management's 13F filing for Q4 2015, filed 10 Mar 2016.